Home > Healthcare > Medical Devices > Diagnostic Devices > at home drug of abuse testing market
Get a free sample of At-home Drug of Abuse (DOA) Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of At-home Drug of Abuse (DOA) Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Advancements in diagnostic technologies have led to significant improvements in the accuracy, sensitivity, and user-friendliness of at-home drug testing kits. Manufacturers have introduced innovative testing methods, such as rapid lateral flow tests and point-of-care molecular tests, which deliver quick and reliable results. Industry participants have expanded their product portfolios to encompass a broader range of drugs, including emerging synthetic drugs. This expansion enhances the relevance and utility of at-home drug testing kits, allowing individuals to monitor a wider spectrum of substances.
The global market for at-home drug of abuse testing was reached USD 3.5 billion in 2022 and is estimated to account for USD 7.2 billion by 2032, as it allows individuals to conduct drug tests in the privacy of their own homes.
The test strips segment garnered USD 1.7 billion in the year 2022, as it offers quick and straightforward drug testing procedures, providing convenience to individuals.
U.S. at-home drug of abuse testing market exceeded USD 1.2 billion in 2022 and is predicted to witness substantial growth through 2032, owing to high prevalence of drug abuse and substance use disorders in the country.
Confirm BioSciences, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., bioM